Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Specifically, Medtronic's diabetes and neuromodulation products may be poised for breakout growth, and the company's up-and-coming products in various stages of development offer promise as well.

Medtronic Chairman and CEO Geoffrey Martha discusses Johnson & Johnson acquiring V-Wave on 'The Claman Countdown.' 14 Things To Avoid Ordering At Wendy's And Why I'm 31, single and just received a ...

Strategics tend to invest in med-tech companies they are looking to acquire or could be acquired. Furthermore, companies like ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic's business is diversified. The company boasts dozens of devices across four main segments: Medical surgical, neuroscience, cardiovascular, and diabetes. Though Medtronic records ...

Shares of Medtronic PLC climbed toward a three-month ... amid strength in its diabetes and cardiovascular business. The company raised the lower ends of its full-year guidance ranges for both ...

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

Medtronic delivered a strong first-quarter ... in 2023. This helped the Diabetes segment's organic sales increase by 12.6%. This recovery is particularly important. Weakness in the Diabetes ...

The Ireland-based company also eyes growth across segments such as diabetes and devices for heart disease-focused surgeries. Medtronic also remains "on the hunt" for the right tuck-in deals.